Guideline on Clinical Development of Fixed Combination Medicinal Products
ثبت نشده
چکیده
DISCUSSION IN THE EFFICACY WORKING PARTY June – October 1994 TRANSMISSION TO THE CPMP October 1994 TRANSMISSION TO INTERESTED PARTIES October 1994 DEADLINE FOR COMMENTS 15 April 1995 RE-SUBMISSION TO THE EFFICACY WORKING PARTY October 1995 RE-SUBMISSION TO THE CPMP November 1995 RE-SUBMISSION TO THE EFFICACY WORKING PARTY March 1996 RE-SUBMISSION TO THE CPMP March 1996 APPROVAL BY THE CPMP 17 April 1996 DATE FOR COMING INTO OPERATION 17 October 1996 DRAFT REV. 1 AGREED BY EFFICACY WORKING PARTY January 2008 ADOPTION BY CHMP FOR RELEASE FOR CONSULTATION REV. 1 21 February 2008
منابع مشابه
Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues
This guideline replaces 'Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: Non-clinical and clinical issues' Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues
متن کاملGuideline on non-clinical and clinical development of similar biological medicinal products containing recombinant erythropoietins (Revision)
متن کامل
Guideline on clinical investigation of medicinal products in the treatment of chronic obstructive pulmonary disease (COPD)
Keywords Chronic obstructive pulmonary disease (COPD), airflow obstruction, relief of symptoms, maintenance treatment, exacerbations. 1 correction related to a change on p. 4 Guideline on clinical investigation of medicinal products in the treatment of chronic obstructive pulmonary disease (COPD) EMA/CHMP/700491/2012 2/17 Guideline on clinical investigation of medicinal products in the treatmen...
متن کاملConcept paper on the revision of the guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues
Concept paper on the revision of the guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues
متن کامل